Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · IEX Real-Time Price · USD
1.380
-0.070 (-4.83%)
At close: Apr 26, 2024, 3:28 PM
1.460
+0.080 (5.80%)
After-hours: Apr 26, 2024, 4:00 PM EDT

Protagenic Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1998
Selling, General & Admin
1.211.9731.851.281.431.651.410.57-0.77
Upgrade
Research & Development
3.321.591.140.70.810.880.720.420.460
Upgrade
Other Operating Expenses
00000000.400
Upgrade
Operating Expenses
4.533.564.142.552.092.312.372.231.03-0.77
Upgrade
Operating Income
-4.53-3.56-4.14-2.55-2.09-2.31-2.37-2.23-1.030.77
Upgrade
Interest Expense / Income
0.110.140.50.250.02000.010.010
Upgrade
Other Expense / Income
0.37-0.14-0.11-0.25-0.350.24-0.110.04-0.011.85
Upgrade
Pretax Income
-5-3.56-4.52-2.55-1.75-2.56-2.26-2.28-1.02-1.08
Upgrade
Net Income
-5-3.56-4.52-2.55-1.75-2.56-2.26-2.28-1.02-1.08
Upgrade
Shares Outstanding (Basic)
4443333120
Upgrade
Shares Outstanding (Diluted)
4443333120
Upgrade
Shares Change
0.62%17.17%42.57%0.76%--93.39%-19.77%25465.70%299.94%
Upgrade
EPS (Basic)
-1.15-0.82-1.24-1.00-0.68-1.00-0.88-1.72-0.60-
Upgrade
EPS (Diluted)
-1.15-0.82-1.24-1.00-0.68-1.00-0.88-1.72-0.60-
Upgrade
Free Cash Flow
-3.85-2-2.8-1.35-0.49-1.07-1.38-1.14-0.38-0.79
Upgrade
Free Cash Flow Per Share
-0.89-0.46-0.76-0.52-0.19-0.42-0.54-0.86-0.23-122.32
Upgrade
EBITDA
-4.86-3.42-4.03-2.3-1.73-2.56-2.26-2.27-1.01-1.08
Upgrade
Depreciation & Amortization
0.03000000000
Upgrade
EBIT
-4.89-3.42-4.03-2.3-1.74-2.56-2.26-2.27-1.01-1.08
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).